Kim Graham
Chief Executive Officer at Innomab, Inc.
Profile
Kim Graham is the founder and Chief Executive Officer of Innomab, Inc., a company founded in 2008.
Mr. Graham has also held former positions as Director at AbGenomics International, Inc., VP-Drug Development & Director-Drug Evaluation at Roche Bioscience, Vice President at Syntex Corp., Vice President-Drug Development at Genencor International, Inc., Vice President & General Manager at MedImmune Ltd., and Senior Vice President-Development at Global Blood Therapeutics, Inc. Mr. Graham received an undergraduate degree from Stanford University and a graduate degree from the University of Oregon.
Kim Graham active positions
| Companies | Position | Start |
|---|---|---|
Innomab, Inc.
 Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | Chief Executive Officer | 03/11/2009 |
Former positions of Kim Graham
| Companies | Position | End |
|---|---|---|
Roche Bioscience
 Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Corporate Officer/Principal | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| Syntex Corp. | Corporate Officer/Principal | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Corporate Officer/Principal | - |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Training of Kim Graham
| Stanford University | Undergraduate Degree |
| University of Oregon | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
| Syntex Corp. | Health Technology |
Innomab, Inc.
Innomab, Inc. Medical/Nursing ServicesHealth Services Innomab, Inc. provides medical services. It specializes in development of innovative monoclonal antibodies in oncology. The company was founded by Kristine Chavez, Kim Graham, and Chuck Smith in 2008 and is headquartered in Redwood City, CA. | Health Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Bioscience
Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Kim Graham
